FK 906

an orally active human renin inhibitor; used for the long-term treatment of patients with essential hypertension; structure given in first source

Also Known As:

1-cyclohexyl-3-hydroxy-6-methyl-2-(N(alpha)-methyl-N(alpha)-(2-(N-methyl-N-(2-(N-methyl-N-morpholinocarbonylamino)ethyl)aminocarbonyloxy)-3-phenylpropionyl)histidyl)aminoheptane hydrochloride; FK-906; FK906

Networked: 1 relevant articles (1 outcomes, 0 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Amino Acids, Peptides, and Proteins: 1
- Amino Acids: 30675
  - Essential Amino Acids: 1152
    - Histidine: 2980
      - FK 906: 1
  - Cyclic Amino Acids: 3
    - Histidine: 2980
      - FK 906: 1
Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Oxazines: 9
    - Morpholines: 6
      - FK 906: 1

Related Diseases

1.	Essential Hypertension 05/01/1993 - "The antihypertensive efficacy of a newly developed orally active human renin inhibitor (FK906) was evaluated in 14 patients with essential hypertension aged 40 to 83 years (mean, 64 years). "

Related Drugs and Biologics

1.	Antihypertensive Agents (Antihypertensives)
2.	Renin Inhibitors